On Friday, Shares of Merck & Co. Inc. (NYSE:MRK), lost -1.77% to $57.87.
Merck Serono, the biopharmaceutical business of Merck, recently declared that the two innovative fertility technologies Gavi and Geri have cleared a major milestone, achieving CE Mark certification. Merck recently signed a global partnership agreement with Genea Biomedx, the manufacturer of both products. With this partnership, Merck Serono received global marketing and commercialization rights to Genea Biomedx’s product portfolio. All products will be offered through Merck Serono’s Fertility Technologies unit.
Merck Serono is the biopharmaceutical business of Merck. With headquarters in Darmstadt, Germany , Merck Serono offers leading brands in 150 countries to assist patients with cancer, multiple sclerosis, infertility, endocrine and metabolic disorders in addition to cardiovascular diseases. In the United States and Canada , EMD Serono operates as a separately incorporated partner of Merck Serono.
Shares of Magnum Hunter Resources Corp. (NYSE:MHR), declined -3.62% to $1.33, during its last trading session, hitting its lowest level, as oil prices continued their recent losses.
WTI crude oil for July delivery was down 1% to $60.18 a barrel Friday morning, and Brent crude oil for July delivery was down 0.8% to $64.57 a barrel.
Magnum Hunter Resources Corporation, an independent oil and gas company, explores for, exploits, acquires, develops, and produces crude oil, natural gas, and natural gas liquid resources in the United States. The company operates through the U.S. Upstream, Midstream, and Oilfield Services segments.
Finally, Johnson Controls Inc. (NYSE:JCI), ended its last trade with -1.17% loss, and closed at $52.35.
Johnson Controls, declared that it is exploring planned options for the separation of its automotive business.
The JCOS reflects “the Johnson Controls way” and provides an operational vehicle to create value through systemic application of planned capabilities across the company. As talk abouted at the company’s analyst meeting in December 2014, the JCOS is already delivering results and is predictable to yield $2 billion in incremental segment income by 2020 through operational effectiveness and raised speed to market.
Johnson Controls said it had no specific timetable for the completion of the planned review, which comprises a full range of planned options for the automotive business. The company is also ongoing to actively evaluate growth platforms that are aligned with the unique operational capabilities and specific attributes of its multi-industrial portfolio.
Johnson Controls has engaged Goldman Sachs and Centerview Partners to serve as financial advisors, and Wachtell, Lipton, Rosen and Katz to serve as legal advisor in connection with this planned review.
Johnson Controls, Inc. operates as a diversified technology and industrial company worldwide. Its Building Efficiency segment designs, produces, markets, and installs integrated heating, ventilating, and air conditioning systems, in addition to building administration systems, controls, and security and mechanical equipment.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
